THEODORE OKON

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Prior authorization and step therapy issues Medicare physician fee schedule payment cuts to radiation therapy

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Prior authorization and step therapy issues Medicare physician fee schedule payment cuts to radiation therapy

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Prior authorization and step therapy issues.

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Enhancing Oncology Model issues/problems (CMS/CMMI)

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Prior authorization and step therapy issues.

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Enhancing Oncology Model issues/problems (CMS/CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Continuing Resolution Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Continuing Resolution Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Continuing Resolution Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Continuing Resolution Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (S. 3458) Multiple pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Change Healthcare cyber attack Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Hospital site-neutral payments Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number) Enhancing Oncology Model (CMMI)

CMS FAQ on Stark mailing drugs violation (no bill number) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Enhancing Oncology Model (EOM) (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (no bill number) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (no specific bill numbers) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Enhancing Oncology Model (EOM) (no specific bill number) Inflation Reduction Act (H.R. 5376)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (no bill number) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Enhancing Oncology Model (EOM) (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (s. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (s. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (s. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (no bill number) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Enhancing Oncology Model (EOM) (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Timely Access to Critical Treatment Act (H.R. 4011) Cancer drug shortages (no specific bill number)

CMS FAQ on Stark mailing drugs violation (no bill number) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (no specific bill numbers) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Enhancing Oncology Model (EOM) (no specific bill number) Inflation Reduction Act (H.R. 5376)

CMS FAQ on Stark mailing drugs violation (H.R. 5526) (s. 3458) Misc pharmacy benefit managers (PBMs) issues relating to cancer care (general issues and multiple bills supporting) Pharmacy Benefit Manager Transparency Act (S. 127) Misc. 340B Drug Discount Program issues (no specific bill number) Medicare physician payment issues (no specific bill number) Inflation Reduction Act (H.R. 5376) Cancer drug shortages (no specific bill number)

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF.

Inflation Reduction Act (H.R. 5376) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S. 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF.

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF.

Inflation Reduction Act (H.R. 5376) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S. 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Inflation Reduction Act (H.R. 5376) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S. 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF.

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF.

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) CMS proposed rule to reform PBM DIR fees TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF.

Inflation Reduction Act (H.R. 5376) Misc pharmacy benefit manager (PBM) issues including DIR fees, delaying cancer patients' treatments, step therapy (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S. 1909) Pharmacy Benefit Manager Transparency Act of 2022 (S. 4293) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Inflation Reduction Act (HR 5376) CMMI Oncology Payment Reform

Extend the moratorium on the application of the sequester cut to Medicare payments. (HR 1868 and as amended in the Senate) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems.

Extend the moratorium on the application of the sequester cut to Medicare payments. (HR 1868 and as amended in the Senate) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation.

Extend the moratorium on the application of the sequester cut to Medicare payments. (HR 1868 and as amended in the Senate) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation.

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Misc. provisions related to HR 3.

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Misc. provisions related to HR 3.

Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Misc. provisions related to HR 3.

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Misc. provisions related to HR 3.

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Misc. provisions related to HR 3.

Drug pricing aspects of the Build Back Better Act (HR 5376); House & Senate Extend the moratorium on the application of the sequester cut to Medicare payments into 2022 (no specific bill) Misc pharmacy benefit manager (PBM) issues including DIR fees and delaying cancer patients' treatments. (no specific bills) Pharmacy DIR Reform To Reduce Senior Drug Costs Act (S 1909) TACT Act (HR 3258) to ensure cancer patients get their oral cancer drugs from PBMs within 72 hours. Exposing hospitals not complying with HHS/CMS regulations to publish price transparency data. (no specific bills) Working on 340B legislation that ensures patients in need receive the discounts, not DSH hospital systems. Hospital and PBM consolidation. CMS/CMMI payment models, including the OCM and OCF. Misc. provisions related to HR 3.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (HR748). Expanding telehealth use (general and HR748). Stopping insurer prior authorization requirements during the COVID-19 crisis (no bill). Fixing the 340B drug discount program (no bill). Misc. issues dealing with pharmacy benefit managers (no bill). Step therapy and prior authorization (general). Oncology Care Model (no bill). Oncology Care First Model (no bill). CMMI guardrail bill (HR5741).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (HR748). Expanding telehealth use (general and HR748). Stopping insurer prior authorization requirements during the COVID-19 crisis (no bill). Fixing the 340B drug discount program (no bill). Misc. issues dealing with pharmacy benefit managers (no bill). Step therapy and prior authorization (general). Oncology Care Model (no bill). Oncology Care First Model (no bill). CMMI guardrail bill (HR5741).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program (no bill). Misc. issues dealing with pharmacy benefit managers (no bill). Various drug pricing/costs (general and Prescription Drug Pricing Reduction Act of 2019; S2542). Step therapy and prior authorization (general and Improving Seniors' Timely Access to Care Act of 2019; HR3107). International Pricing Index Model (no bill). Oncology Care Model (no bill). Oncology Care First Model (no bill). CMMI guardrail bill (no bill number; not introduced).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program (no bill). Misc. issues dealing with pharmacy benefit managers (no bill). Various drug pricing/costs (general and Prescription Drug Pricing Reduction Act of 2019; S2542). Step therapy and prior authorization (general and Improving Seniors' Timely Access to Care Act of 2019; HR3107). International Pricing Index Model (no bill). Oncology Care Model (no bill). Oncology Care First Model (no bill). CMMI guardrail bill (no bill number; not introduced).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). STEP therapy (no bill). International Pricing Index Model (no bill)

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Various drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network. STEP therapy (no bill).

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710), HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) and other legislation in progress. Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Moving Medicare Part B to Part D (no bill). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act; H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act; and H.R. 5958 - Phair Pricing Act of 2018}. Oncology Care Model (CMS/CMMI; no bill). Drug pricing/costs (no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.

Stopping the application of the sequester cut (current and new) to Medicare Part B drug reimbursement (no bill). Fixing the 340B drug discount program, including PAUSE Act (H.R. 4710, HELP Act (S. 2312, and Ensuring the Value of the 340B Program Act (S. 2453) Fixing Medicare Part B drug reimbursement by eliminating the manufacturer-to-wholesaler prompt pay discount from the calculation of average sales price, the basis of Part B drug reimbursement (H.R. 1920, S. 1304). Misc. issues dealing with pharmacy benefit managers and patient and pharmacy abuses (includes bills H.R 1316 - Prescription Drug Price Transparency Act and H.R.1038 - Improving Transparency and Accuracy in Medicare Part D Spending Act}. Medicare oncology payment reform (includes bills S. 463 - Cancer Care Payment Reform Act of 2017 and H.R. 1834 - Cancer Care Payment Reform Act of 2017. Oncology Care Model (CMS/CMMI; no bill). VA clawback of payments made to community oncology practices for treating veterans out of network.